“Examining the Therapeutic Potential of CRISPR-Cas9 Gene Editing in Spondyloarthritis: Efficacy of TNF Inhibitor Adalimumab: Research Article”, IJRMCS, vol. 2, no. 02, pp. 20–30, Jul. 2024, doi: 10.70829/ijrmcs.v2.i2.0724002.